

IMPORTANT SAFETY INFORMATION—UCERIS extended release tablets
IMPORTANT SAFETY INFORMATION—UCERIS extended release tablets
To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information for UCERIS extended release tablets.
Salix Product Information Call Center
Phone: 1-800-321-4576
Email: salixmc@dlss.com
To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information for UCERIS extended release tablets.
Salix Product Information Call Center
Phone: 1-800-321-4576
Email: salixmc@dlss.com